235 related articles for article (PubMed ID: 1898652)
1. Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women.
Van Erpecum KJ; Van Berge Henegouwen GP; Verschoor L; Stoelwinder B; Willekens FL
Gastroenterology; 1991 Feb; 100(2):482-8. PubMed ID: 1898652
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women.
Uhler ML; Marks JW; Voigt BJ; Judd HL
J Clin Endocrinol Metab; 1998 Feb; 83(2):410-4. PubMed ID: 9467549
[TBL] [Abstract][Full Text] [Related]
3. Biologic effects of transdermal estradiol.
Chetkowski RJ; Meldrum DR; Steingold KA; Randle D; Lu JK; Eggena P; Hershman JM; Alkjaersig NK; Fletcher AP; Judd HL
N Engl J Med; 1986 Jun; 314(25):1615-20. PubMed ID: 3012339
[TBL] [Abstract][Full Text] [Related]
4. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure.
Steingold KA; Matt DW; DeZiegler D; Sealey JE; Fratkin M; Reznikov S
J Clin Endocrinol Metab; 1991 Aug; 73(2):275-80. PubMed ID: 1906893
[TBL] [Abstract][Full Text] [Related]
5. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
6. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
7. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
Slowinska-Srzednicka J; Zgliczynski S; Jeske W; Stopinska-Gluszak U; Srzednicki M; Brzezinska A; Zgliczynski W; Sadowski Z
J Endocrinol Invest; 1992; 15(7):533-8. PubMed ID: 1280287
[TBL] [Abstract][Full Text] [Related]
8. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women.
Vehkavaara S; Hakala-Ala-Pietilä T; Virkamäki A; Bergholm R; Ehnholm C; Hovatta O; Taskinen MR; Yki-Järvinen H
Circulation; 2000 Nov; 102(22):2687-93. PubMed ID: 11094033
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
Adami S; Rossini M; Zamberlan N; Bertoldo F; Dorizzi R; Lo Cascio V
Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
12. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
De Lignieres B; Basdevant A; Thomas G; Thalabard JC; Mercier-Bodard C; Conard J; Guyene TT; Mairon N; Corvol P; Guy-Grand B
J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464
[TBL] [Abstract][Full Text] [Related]
13. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism.
Ho KK; Weissberger AJ
J Bone Miner Res; 1992 Jul; 7(7):821-7. PubMed ID: 1642149
[TBL] [Abstract][Full Text] [Related]
14. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.
Friend KE; Hartman ML; Pezzoli SS; Clasey JL; Thorner MO
J Clin Endocrinol Metab; 1996 Jun; 81(6):2250-6. PubMed ID: 8964860
[TBL] [Abstract][Full Text] [Related]
15. Transdermal oestrogen for postmenopausal women: a double blind crossover comparative study with ethinyl oestradiol.
Pattison NS; Uptin T; Knox B; France J
Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):62-5. PubMed ID: 2562605
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
O'Sullivan AJ; Ho KK
J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climacteric symptoms in postmenopausal women.
Selby P; McGarrigle HH; Peacock M
Clin Endocrinol (Oxf); 1989 Mar; 30(3):241-9. PubMed ID: 2512035
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
[TBL] [Abstract][Full Text] [Related]
19. [Effect of a 17 beta estradiol gel preparation on hormone levels in menopausal women].
Araya V; Contreras P; Aguirre C; Foradori A
Rev Med Chil; 1995 Sep; 123(9):1116-21. PubMed ID: 8728735
[TBL] [Abstract][Full Text] [Related]
20. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
Janssen YJ; Helmerhorst F; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
